We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biovail Suffers One-Two Punch In Wellbutrin XL Feud

Law360 (August 2, 2006, 12:00 AM EDT) -- In a setback for Canada’s Biovail Corp. in the ongoing legal battle over its blockbuster drug Wellbutrin XL, a federal judge on Tuesday granted Anchen Pharmaceuticals Inc. a key part of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.